Rapport Therapeutics (RAPP) EBITDA

Annual EBITDA

-$34.66 M
NaN%

December 31, 2023


Summary


Performance

RAPP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRAPPprofitabilitymetrics:

Quarterly EBITDA

-$21.42 M
-$829.00 K-4.03%

September 30, 2024


Summary


Performance

RAPP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRAPPprofitabilitymetrics:

TTM EBITDA

-$72.29 M
-$11.88 M-19.66%

September 30, 2024


Summary


Performance

RAPP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRAPPprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

RAPP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--26.4%-55.7%
3 y3 years--313.9%-1296.7%
5 y5 years--313.9%-1296.7%

RAPP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-313.9%at low-1296.7%at low
5 y5-yearat highat low-313.9%at low-1296.7%at low
alltimeall timeat highat low-313.9%at low-1296.7%at low

Rapport Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$21.42 M(+4.0%)
-$72.29 M(+19.7%)
Jun 2024
-
-$20.59 M(+21.5%)
-$60.41 M(+30.1%)
Mar 2024
-
-$16.94 M(+27.0%)
-$46.43 M(+33.9%)
Dec 2023
-$34.66 M
-
-
DateAnnualQuarterlyTTM
Dec 2023
-
-$13.34 M(+39.8%)
-$34.66 M(+62.5%)
Sep 2023
-
-$9.54 M(+44.4%)
-$21.33 M(+81.0%)
Jun 2023
-
-$6.61 M(+27.7%)
-$11.79 M(+127.7%)
Mar 2023
-
-$5.18 M
-$5.18 M

FAQ

  • What is Rapport Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Rapport Therapeutics?
  • What is Rapport Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Rapport Therapeutics?
  • What is Rapport Therapeutics quarterly EBITDA year-on-year change?
  • What is Rapport Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Rapport Therapeutics?
  • What is Rapport Therapeutics TTM EBITDA year-on-year change?

What is Rapport Therapeutics annual EBITDA?

The current annual EBITDA of RAPP is -$34.66 M

What is the all time high annual EBITDA for Rapport Therapeutics?

Rapport Therapeutics all-time high annual EBITDA is -$34.66 M

What is Rapport Therapeutics quarterly EBITDA?

The current quarterly EBITDA of RAPP is -$21.42 M

What is the all time high quarterly EBITDA for Rapport Therapeutics?

Rapport Therapeutics all-time high quarterly EBITDA is -$5.18 M

What is Rapport Therapeutics quarterly EBITDA year-on-year change?

Over the past year, RAPP quarterly EBITDA has changed by -$4.48 M (-26.44%)

What is Rapport Therapeutics TTM EBITDA?

The current TTM EBITDA of RAPP is -$72.29 M

What is the all time high TTM EBITDA for Rapport Therapeutics?

Rapport Therapeutics all-time high TTM EBITDA is -$5.18 M

What is Rapport Therapeutics TTM EBITDA year-on-year change?

Over the past year, RAPP TTM EBITDA has changed by -$25.86 M (-55.70%)